Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4–AKT–ATP‐binding cassette G2 pathway†
Hepatology2010Vol. 52(2), pp. 528–539
Citations Over TimeTop 10% of 2010 papers
Xiao Qi Wang, Weg M. Ongkeko, Lin Chen, Zhen Yang, Ping Lü, Kwok Kin Chen, Jay Patrick Lopez, Ronnie T.P. Poon, Sheung Tat Fan
Abstract
Oct4, a transcriptional factor of pluripotent cells, can mediate chemoresistance through a potential Oct4-AKT-ABCG2 pathway.
Related Papers
- → Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex(2020)62 cited
- → Inhibition of Akt Kinase Activity by a Peptide Spanning the βA Strand of the Proto-oncogene TCL1(2004)91 cited
- → Regulation of neutrophil apoptosis by modulation of PKB/Akt activation(2009)34 cited
- → Photo-Activatable Akt Probe: A New Tool to Study the Akt-Dependent Physiopathology of Cancer Cells(2017)1 cited
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)